MD Medical Group IPJSC ("MD Medical", "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces audited consolidated financial results for 6M ended 30 June 2026 under IFRS.

Key financial highlights for H1 2026[1]:

• The Group’s total revenue grew by 28.8% y-o-y to RUB 24,809 million, driven primarily by growth in revenue from in-patient treatments and deliveries. Like-for-like (LFL) revenue increased by 11.2% y-o-y to RUB 21,416 million.

• EBITDA went up by 20% y-o-y to RUB 6,986 million. EBITDA margin was 28.2%, compared to 30.2% in H1 2025. The dynamics are driven by the increase in the Company’s staffing levels for the acquired and newly established medical facilities, as well as by the process of integrating new assets, which also contributes to an increase in functional expenses.

• Net profit increased by 5.1% to RUB 5,323 million. Net profit margin was 21.5%, compared to 26.3% in H1 2025, due to a decline in net finance income and an increase in interest expense on lease liabilities and depreciation and amortisation charges related to the acquisition of the Expert medical centres.

• Operating cash flow increased by 16.7% y-o-y to RUB 7,060 million.

• Total Capex in H1 2026 reached RUB 2,577 million, up 90.2%, mainly due to the final settlement in Q1 of a property acquisition deal for a new hospital in Moscow.

• The Group’s net debt as at 30 June 2026 stood at RUB 6,261 million, including RUB 3,706 million of lease liabilities[2], with the Net debt/EBITDA LTM at 0.4x.

Key operational highlights for H1 2026[3]:

• Total out-patient treatments increased by 71.2% y-o-y to 2,692,178.

• Total in-patient treatments decreased by 0.7% y-o-y to 72,092, the number of surgeries grew 28.6%.

• Total deliveries increased by 12.5% y-o-y to 6,701.

• Total IVF punctures increased by 0.9% y-o-y to 10,594.

Key events during H1 2026 and after the reporting period:

Expansion of the clinic in Moscow. On 8 July 2026 one of the first clinics of the Group, Mother&Child Ugo-Zapad multifunctional family center moved to a new building covering an area of 1,077 sq m, which is 276 sq. m. more than the previously occupied premises. The clinic's capacity allows for 78,000 patient appointments per year, which is 12,000 more than the previous capacity, and 1,600 IVF punctures per year. Investments in the clinic expansion amounted to RUB 162 mln.

Holding the Annual General Meeting of Shareholders. On 25 June 2026, at the Company's Annual General Meeting of Shareholders, a decision was made to distribute part of the Company’s net profit for the 2025 financial year in the amount of RUB 3,530,875,470 as dividend payments.

Acquisition of Ilyinskaya Hospital. On 24 June 2026, MD Medical Group announced the acquisition of Ilyinskaya Hospital, a large multidisciplinary facility in Moscow Region with a total area of 14,088 sq m, opened in 2019. The acquisition price is RUB 8.5 billion, including RUB 1.1 billion of debt on the acquired asset's balance sheet. Payment is made using a combination of the Company’s own and borrowed funds.

Acquisition of out-patient network in Novosibirsk. On 17 June 2026, MD Medical Group announced the acquisition of Zdravitsa, the leading out-patient network in Novosibirsk that covers six out-patient centres with a total area of 4,200 sq m. The clinics can handle 525,000 out-patient appointments per year. The fixed transaction amount is RUB 900 million, to be paid with the Company’s own cash resources.

Expansion of the clinic in Tula. On 1 April 2026 the total area of the Mother and Child Clinic in Tula increased by 95 square meters and now covers the total area of 636 square meters. The updated clinic will increase the patient flow and capacity of the Group's popular clinic from 24,000 visits to 42,000 visits per year. Investments in the clinic expansion amounted to RUB 18.5 mln.

Opening new clinic in Moscow. On 20 March 2026 MD Medical Group opened its clinic in Kurkino district of Moscow, which specializes in a wide range of medical services for women's health, with a total area of 289 sq m. The clinic has a capacity of 42,000 appointments per year. Total investment in opening and equipping the clinic came to RUB 55 million.

New clinic in Novorossiysk launched. On 9 February 2026 MD Medical Group opened Mother & Child Novorossiysk clinic spanning 206 sq m and specializing in a wide range of medical services for women's health. The clinic's capacity allows for 24,000 out-patient visits per year. Total investment in opening and equipping the clinic came to RUB 60 million.

MD Medical CEO Mark Kurtser said:

“With H1 2026 now behind us, we are moving forward with confidence: the Company's revenue grew by 29%, reflecting both growing patient trust and the right development strategy. Our margins are still among the highest in the commercial healthcare market, with EBITDA margin at 28%.

We are expanding on several fronts at once – through the efficient use of existing capacity, organic development, and the completion of M&A deals. By consolidating high-quality assets, we are broadening our competencies and geographical footprint to bring medical care within reach of new groups of patients. These acquisitions make our business model even more diversified and resilient, not least through well-thought-out patient routing between our facilities, while our team keeps getting stronger as we bring together top specialists and build up the chain’s professional capacity.

Our near-term strategy has a clear focus: continuing organic development by preparing new medical facilities for opening and expanding existing clinics, while working purposefully to improve the operational efficiency of new assets – benefits we expect to see materialise next year. A balanced approach to capital investment needs, combined with a moderate leverage, will let us maintain our practice of regular dividend payments. In H2 2026, with the Board of Directors’ support, we plan to allocate part of the period’s profit to dividends.”

[1] The Company's income and expenses in the reporting period were significantly affected by the full consolidation of the Expert medical centres (in H1 2025, Expert’s results were recognised only from 22 May).

[2] According to IFRS 16, the Company’s lease liabilities are recognised as debt.

[3] For more details on operational highlights, see our press release dated 31 July 2026

Notes:

1. This announcement may contain inside information
2. Minor deviations in the calculation of totals, subtotals and/or percent changes are due to rounding
3. The Group’s consolidated financial statements are available on the Group’s website: www.mcclinics.com/investors/financial-reports/

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 97 state-of-the-art healthcare facilities, including 15 multidisciplinary hospitals and 82 out-patient clinics in 35 regions of the Russian Federation. In 2025, MD Medical Group's revenue amounted to RUB 43.5 bln. while EBITDA stood at RUB 13.3 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).